MX2009009065A - Proceso para sintesis de inhibidores del transportador de glicina 1. - Google Patents

Proceso para sintesis de inhibidores del transportador de glicina 1.

Info

Publication number
MX2009009065A
MX2009009065A MX2009009065A MX2009009065A MX2009009065A MX 2009009065 A MX2009009065 A MX 2009009065A MX 2009009065 A MX2009009065 A MX 2009009065A MX 2009009065 A MX2009009065 A MX 2009009065A MX 2009009065 A MX2009009065 A MX 2009009065A
Authority
MX
Mexico
Prior art keywords
alkyl
compound
formula
halogen
nr4r5
Prior art date
Application number
MX2009009065A
Other languages
English (en)
Spanish (es)
Inventor
Shaoning Wang
Pius Waldmeier
Christophe Pfleger
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2009009065A publication Critical patent/MX2009009065A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • A61K31/497Non-condensed pyrazines containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX2009009065A 2007-03-05 2008-02-25 Proceso para sintesis de inhibidores del transportador de glicina 1. MX2009009065A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07103485 2007-03-05
PCT/EP2008/052244 WO2008107334A2 (en) 2007-03-05 2008-02-25 Process for the synthesis of glyt-1 inhibitors

Publications (1)

Publication Number Publication Date
MX2009009065A true MX2009009065A (es) 2009-08-31

Family

ID=39469606

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009009065A MX2009009065A (es) 2007-03-05 2008-02-25 Proceso para sintesis de inhibidores del transportador de glicina 1.

Country Status (13)

Country Link
US (1) US7812161B2 (show.php)
EP (1) EP2131843B1 (show.php)
JP (1) JP4745446B2 (show.php)
KR (1) KR101143073B1 (show.php)
CN (1) CN101622000B (show.php)
AT (1) ATE532516T1 (show.php)
AU (1) AU2008223915B2 (show.php)
BR (1) BRPI0808570B8 (show.php)
CA (1) CA2678630C (show.php)
ES (1) ES2375585T3 (show.php)
IL (1) IL200323A (show.php)
MX (1) MX2009009065A (show.php)
WO (1) WO2008107334A2 (show.php)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5656474B2 (ja) 2010-06-28 2015-01-21 関東化学株式会社 脂肪族光学活性フルオロアルコールの製造方法
CN104628679B (zh) * 2013-11-08 2018-02-09 江苏恩华药业股份有限公司 Bitopertin的合成方法及其中间体
CN106397312B (zh) * 2015-07-31 2020-03-24 广东东阳光药业有限公司 一种制备glyt-1抑制剂的方法
EP4087570A4 (en) 2020-01-09 2024-04-03 Disc Medicine, Inc. METHODS OF TREATING ERYTHROPOIETIC PROTOPORPHYRIA, X-LINKED PROTOPORPHYRIA OR CONGENITAL ERYTHROPOIETIC PORPHYRIA WITH GLYCINE TRANSPORT INHIBITORS
EP4229051A1 (en) 2020-10-13 2023-08-23 Boehringer Ingelheim International GmbH Process of reworking
CN119768399A (zh) 2022-08-24 2025-04-04 勃林格殷格翰国际有限公司 GlyT-1抑制剂的可规模化制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992441A (en) * 1972-12-26 1976-11-16 Pfizer Inc. Sulfamylbenzoic acids
US4480102A (en) * 1982-07-23 1984-10-30 The Dow Chemical Company 2,3-Difluoro-5-(trifluoromethyl)pyridine and methods of making and using the same
IE62792B1 (en) * 1988-11-24 1995-03-08 Akzo Nv Pharmaceutical composition containing 1-(mono- or bis (Trifluoromethyl)-2-pyridinyl) piperazines
DE4235155A1 (de) * 1992-10-19 1994-04-21 Basf Ag Verfahren zur Herstellung von Methylsulfonylbenzoesäuren
KR20010042851A (ko) * 1998-04-20 2001-05-25 후지야마 아키라 cGMP 포스포디에스터라제 억제자로서의 안트라닐산유도체
DE10112040A1 (de) * 2001-03-14 2002-10-02 Aventis Pharma Gmbh Verbessertes Verfahren zur Herstellung von Sulfonylcarboxamidderivaten
GB0227240D0 (en) * 2002-11-21 2002-12-31 Glaxo Group Ltd Compounds
CN1867554B (zh) * 2003-08-11 2011-07-06 弗·哈夫曼-拉罗切有限公司 具有邻-取代的苯基的哌嗪及其作为glyt1抑制剂的用途
AU2005313581B2 (en) * 2004-12-09 2011-06-09 F. Hoffmann-La Roche Ag Phenyl-piperazin methanone derivatives
CA2593453A1 (en) * 2005-01-06 2006-07-13 F. Hoffmann-La Roche Ag Sulfanyl substituted phenyl methanones as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
ATE472327T1 (de) * 2005-01-07 2010-07-15 Hoffmann La Roche Ä4-(heteroaryl)piperazin-1-ylü-(2,5-substituier e phenyl)methanon-derivate als glycin-transporter 1 (glyt-1) hemmer zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
MX2008000260A (es) * 2005-07-08 2008-03-24 Hoffmann La Roche Reduccion asimetrica de 1,1,1-trifluoroacetona.

Also Published As

Publication number Publication date
CA2678630C (en) 2015-04-14
US20080221327A1 (en) 2008-09-11
KR101143073B1 (ko) 2012-05-08
BRPI0808570B1 (pt) 2020-09-15
EP2131843B1 (en) 2011-11-09
BRPI0808570B8 (pt) 2021-05-25
CN101622000A (zh) 2010-01-06
IL200323A0 (en) 2010-04-29
WO2008107334A2 (en) 2008-09-12
US7812161B2 (en) 2010-10-12
BRPI0808570A2 (pt) 2014-09-02
JP2010520251A (ja) 2010-06-10
AU2008223915A1 (en) 2008-09-12
EP2131843A2 (en) 2009-12-16
ATE532516T1 (de) 2011-11-15
KR20090110368A (ko) 2009-10-21
IL200323A (en) 2013-11-28
CA2678630A1 (en) 2008-09-12
CN101622000B (zh) 2012-07-04
AU2008223915B2 (en) 2013-05-02
WO2008107334A3 (en) 2008-10-23
JP4745446B2 (ja) 2011-08-10
ES2375585T3 (es) 2012-03-02

Similar Documents

Publication Publication Date Title
MX2009009065A (es) Proceso para sintesis de inhibidores del transportador de glicina 1.
MXPA05008619A (es) Derivados novedosos de 2-piridincarboxamida.
MY153045A (en) Oxopyrazine derivative and herbicide
MY146660A (en) Process for preparing biaryl substituted 4-amino-butyric acid or derivatives thereof and their use in the production of nep inhibitors
MEP8409A (en) Fused heterocyclic compound
NO20064669L (no) Dipeptidylpeptidaseinhibitorer
JO2808B1 (en) Compounds and their preparation and pharmaceutical compounds
NO20075809L (no) DNA-PK inhibitorer
MX2009012380A (es) Compuestos de heteroarilamida pirimidona.
NO20082877L (no) Forloperforbindelse til radioaktiv halogenmerket organisk forbindelse
TW200744659A (en) Preparation for preventing and ameliorating wrinkle
UA97638C2 (ru) Способ синтеза ранелата стронция и его гидратов
BRPI0409471A (pt) processo para a preparação de 2-cianopirrolidinas n-substituìdas
MX2025004774A (es) Proceso para la preparacion de un agente de contraste de gadolinio
BR0012771A (pt) Processo para preparar uma composição de esterquat
TNSN07395A1 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
WO2008117871A1 (ja) 含窒素レドックス触媒
DK1532098T3 (da) Fremgangsmåde til fremstilling af nitrooxyderivater af naproxen
TW200745104A (en) Multikinase inhibitor
ATE495158T1 (de) Substituierte tetrahydroisochinoline als mmp- inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
TW200604161A (en) Chemical process
JO2433B1 (en) Preparation of heterocyclic lindane landscapes
WO2008114622A1 (ja) 酸化発色化合物またはその塩およびその製造方法、ならびに試薬組成物およびこれを用いた試験具
NO20030781L (no) Prodrugs til NMDA-reseptor-ligander
TW200718673A (en) Process for producing aromatic sulfonic acid compound

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration